Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Karin, Welén"'
Publikováno v:
Methods and Protocols, Vol 6, Iss 6, p 118 (2023)
Bone metastases cause morbidity and mortality in several human cancer forms. Experimental models are used to unravel the mechanisms and identify possible treatment targets. The location inside the skeleton complicates accurate assessment. This study
Externí odkaz:
https://doaj.org/article/c9ef7a4f6d49406687fdffc3de0c1e33
Autor:
Elin Thysell, Linda Köhn, Julius Semenas, Helena Järemo, Eva Freyhult, Marie Lundholm, Camilla Thellenberg Karlsson, Jan‐Erik Damber, Anders Widmark, Sead Crnalic, Andreas Josefsson, Karin Welén, Rolf J. A. Nilsson, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 16, Iss 4, Pp 846-859 (2022)
To improve treatment of metastatic prostate cancer, the biology of metastases needs to be understood. We recently described three subtypes of prostate cancer bone metastases (MetA‐C), based on differential gene expression. The aim of this study was
Externí odkaz:
https://doaj.org/article/65f5c75dc7eb47b6a1f8e39de3159faa
Autor:
Tom A. Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, Holger Jensen, Tove Olafsen, Paul J. Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, Anna M. Wu, Karin Welén
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Purpose Targeted alpha therapy (TAT) is a promising treatment for micrometastatic and minimal residual cancer. We evaluated systemic α-radioimmunotherapy (α-RIT) of metastatic castration-resistant prostate cancer (mCRPC) using the α-parti
Externí odkaz:
https://doaj.org/article/cb79622cfe444d258013759e1047e094
Autor:
Karin Welén, Anna K Överby, Clas Ahlm, Eva Freyhult, David Robinsson, Anna Jonsson Henningsson, Johan Stranne, Daniel Bremell, Martin Angelin, Elisabeth Lindquist, Robert Buckland, Camilla Thellenberg Carlsson, Karlis Pauksens, Anna Bill-Axelsson, Olof Akre, Cecilia Ryden, Magnus Wagenius, Anders Bjartell, Anna C. Nilsson, Johan Styrke, Johanna Repo, Åse Östholm Balkhed, Katarina Niward, Magnus Gisslén, Andreas Josefsson
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-3 (2021)
Abstract Objectives The main goal of the COVIDENZA trial is to evaluate if inhibition of testosterone signalling by enzalutamide can improve the outcome of patients hospitalised for COVID-19. The hypothesis is based on the observation that the majori
Externí odkaz:
https://doaj.org/article/6eef737882e447dd8478f0b7774aad97
Publikováno v:
The Prostate. 80:799-810
Background Regulator of G-protein signaling 2 (RGS2) is a multifaceted protein with a prognostic value in hormone-naive prostate cancer (PC). It has previously been associated with the development of castration resistance. However, RGS2 expression in
Autor:
Sture Lindegren, Karin Jennbacken, Jan-Erik Damber, Holger Jensen, Karin Welén, Malin Hagberg Thulin, Anna M. Wu, Per Albertsson, Paul J. Yazaki, Stig Palm, Tove Olafsen, Tom Bäck
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
EJNMMI Research
EJNMMI Research
Purpose Targeted alpha therapy (TAT) is a promising treatment for micrometastatic and minimal residual cancer. We evaluated systemic α-radioimmunotherapy (α-RIT) of metastatic castration-resistant prostate cancer (mCRPC) using the α-particle emitt
Autor:
Karin Welén, Ebba Rosendal, Magnus Gisslén, Annasara Lenman, Eva Freyhult, Osvaldo Fonseca-Rodríguez, Daniel Bremell, Johan Stranne, Åse Östholm Balkhed, Katarina Niward, Johanna Repo, David Robinsson, Anna J. Henningsson, Johan Styrke, Martin Angelin, Elisabeth Lindquist, Annika Allard, Miriam Becker, Stina Rudolfsson, Robert Buckland, Camilla Thellenberg Carlsson, Anders Bjartell, Anna C. Nilsson, Clas Ahlm, Anne-Marie Fors Connolly, Anna K. Överby, Andreas Josefsson
Publikováno v:
European Urology
Background: Men are more severely affected by COVID-19. Testosterone may influence SARS-CoV-2 infection and the immune response. Objective: To clinically, epidemiologically, and experimentally evaluate the effect of antiandrogens on SARS-CoV-2 infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e7b2d3bcc8c3fdb681b48e461c1a274
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-480006
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-480006
Metastasis to bone is the leading cause of death from prostate cancer. Interaction between tumor cells and bone cells can promote progression and influence tumor phenotype. It is known that prostate cancer cells support osteoclast differentiation, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66398fd01d313d6b24670977de310cf4
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-495158
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-495158
Autor:
Karin Welén, Ebba Rosendal, Eva Freyhult, William K. Oh, Magnus Gisslén, Clas Ahlm, Anne-Marie Fors Connolly, Anna K. Överby, Andreas Josefsson
Publikováno v:
European Urology. 81:e143-e144
Autor:
null Elin Thysell, null Linda Köhn, null Julius Semenas, null Helena Järemo, null Eva Freyhult, null Marie Lundholm, null Camilla Thellenberg Karlsson, null Jan‐Erik Damber, null Anders Widmark, null Sead Crnalic, null Andreas Josefsson, null Karin Welén, null R. Jonas A. Nilsson, null Anders Bergh, null Pernilla Wikström
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a514af86b0864733ce605988cb9b4fc
https://doi.org/10.1002/1878-0261.13158/v2/response1
https://doi.org/10.1002/1878-0261.13158/v2/response1